小分子誘発によるVibrio cholerae RTXシステインプロテアースドメインのアロステリック活性化
Patrick J Lupardus1, Aimee Shen, Matthew Bogyo
1Department of Molecular and Cellular Physiology and Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
まとめ
Vibrio cholerae RTX毒素は,イノシトールヘキサキスファート (InsP6) を使用して,そのプロテアゼ領域を活性化します. InsP6結合はアロステリックスイッチを誘発し,毒素のエフェクタドメインを解放します.
科学分野:
- 微生物学 微生物学とは
- 構造生物学 構造生物学とは
- バイオケミストリー バイオケミストリー
背景:
- Vibrio cholerae RTXはアクチンを破壊する毒素である.
- 毒素の活性性は,そのシステインプロテアゼ領域 (CPD) によって自動処理に依存しています.
研究 の 目的:
- InsP6.6によるRTX CPDアクティベーションの構造とメカニズムを明らかにする.
- InsP6の結合が毒素の自己処理をどのように引き起こすかを理解するためです.
主な方法:
- RTX CPD-InsP6複合体の構造を2.1アングストームの解像度で決定するためのX線結晶学.
- CPDのサイト指向型変異.
- 生化学的および運動的分析.
主要な成果:
- InsP6と複合したRTX CPDの2.1アングストーム構造を決定した.
- InsP6は,活性部位から遠く離れた保存された基礎裂け目に結合する.
- ミュタゲネーシスと運動データは,InsP6結合がアロステリックスイッチを誘発することを明らかにした.
結論:
- 遠隔裂に結合するInsP6は,RTX CPDをアロステリックに活性化させます.
- このアクティベーションメカニズムは,自動処理とエフェクタドメインの解放につながります.
- この発見は,宿主細胞の代謝産物による細菌毒素の調節に関する洞察を提供します.
関連する概念動画
Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


